Monday 14 May |
Centrica |
Midwich Group |
Safecharge International Group |
Tuesday 15 May |
Amerisur Resources |
Macfarlane Group |
Spirax-Sarco Engineering |
Anglo Pacific Group |
Charles Taylor |
Vitec Group |
IWG |
UBM |
Cairn Energy |
G4S |
Wednesday 16 May |
Indivior |
National Express Group |
Mondi |
Merchants Trust |
Premier Oil |
Chesnara |
Jupiter Fund Management |
Moss Bross |
Coats Group |
Ophir Energy |
Cineworld Group |
Tritax Big Box REIT |
Secure Trust Bank |
Charter Court Financial Services Group |
Utilitywise |
Fenner (re acquisition by Michelin) |
Thursday 17 May |
Just Group |
Hill & Smith Holdings |
Lidco Group |
Fevertree Drinks |
Highcroft Investments |
esure Group |
Foxtons Group |
Hiscox |
Prudential |
Next |
North Midland Construction |
Legal & General Group |
Vectura Group |
Regional REIT |
Staffline Group |
Robert Walters |
Genel Energy |
TI Fluid Systems |
Friday 18 May |
Paddy Power Betfair |
Independent News & Media |
AstraZeneca |
Computacenter |
Clarke (T) |
Petrofac |
John Menzies |
Derwent London |
Hikma Pharmaceuticals |
NEX Group (re acquisition by CME London) |
Hikma reiterates FY guidance amid 'strong momentum'
(Sharecast News) - Drugmaker Hikma Pharmaceuticals reiterated full-year guidance on Thursday, citing "strong momentum" in its injectables and branded units, but also cautioned that had begun to see the effects of the global inflationary environment on costs.
Read more